Neomycin Sulfate + Nystatin + Thiostrepton + Triamcinolone Acetonide (Panolog, Animax): adverse event reports that FDA received
Combination of 4 active ingredients
Also sold as: Panolog, Animax, Derma 4, Derm-Otic.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFrom March 1990 to June 2026, FDA received 997 adverse event reports that name this drug. Its active ingredients are neomycin sulfate, nystatin, thiostrepton and triamcinolone acetonide. Of the 997 reports, 782 (78.4%) are about dogs. 158 reports are about cats (15.8%).
In January to March 2026, FDA received 34 reports that name this drug. The signs that appear in the largest number of the 997 reports are "Deafness", "Vomiting" and "Loss of hearing". A report is not proof that a drug caused a sign.
Reports that name this drug rose by 53.1% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 78.4% of the reports that name this drug, and 72.6% of all reports.
Since the last update of the FDA data
The site recorded an update of the FDA data on . FDA changed these counts for January to March 2026:
- All species: from 28 to 34.
January to March 2026 is the latest closed quarter in the data. In that quarter FDA received 34 reports that name neomycin sulfate + nystatin + thiostrepton + triamcinolone acetonide: 23 dog, 11 cat, 0 horse, 0 other or not given.
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 997 reports that list the sign. One report can list more than one sign.
The sign that is in the largest number of the reports comes first.
- Deafness27.9%278 reports
- Vomiting9.4%94 reports
- Loss of hearing7.9%79 reports
- Lethargy[unusually tired or inactive]6.5%65 reports
- Lack of efficacy - NOS[the product did not have the expected effect]5.5%55 reports
- Temporary deafness5.4%54 reports
- Diarrhoea[diarrhea]4.3%43 reports
- PR-ear(s), lesion(s)[legacy FDA term: lesions found in the ears]4.2%42 reports
- Partial deafness2.9%29 reports
- Anorexia[not eating]2.7%27 reports
- Pruritus[itching]2.7%27 reports
- Other abnormal test result NOS[abnormal laboratory result, type not specified]2.6%26 reports
- Death by euthanasia[the animal was euthanized]2.5%25 reports
- Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]2.4%24 reports
Show the next 16 signs
- Not eating2.4%24 reports
- Skin lesion NOS[NOS: not otherwise specified]2.4%24 reports
- Ataxia[unsteady, uncoordinated movement]2.3%23 reports
- Behavioural disorder NOS[behaviour change, type not specified]2.3%23 reports
- Death2.3%23 reports
- Ear discharge2.3%23 reports
- Accidental exposure[exposure that was not intended]2.2%22 reports
- Application site alopecia[hair loss where the product was applied]2.2%22 reports
- Medication error NOS[a mistake in giving the product, type not specified]2.2%22 reports
- Weight loss2.1%21 reports
- Emesis[vomiting]2%20 reports
- Abnormal cytology1.9%19 reports
- Seizure NOS[seizure, type not specified]1.9%19 reports
- Application site scab[scab where the product was applied]1.8%18 reports
- Decreased appetite1.8%18 reports
- Depression[dull, quiet or withdrawn]1.7%17 reports
The list shows 30 of 821 coded signs. A report is not proof that a drug caused a sign. Download all signs (CSV)
Reports by species
The share is of all 997 reports that name neomycin sulfate + nystatin + thiostrepton + triamcinolone acetonide. The other reports give a different species or no species.
Reports for each month, Jul 2021 to Jun 2026
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 53 | 22 | 0 | 0 | 75 |
| 2025 | 98 | 28 | 0 | 2 | 128 |
| 2024 | 68 | 10 | 0 | 3 | 81 |
| 2023 | 56 | 14 | 1 | 3 | 74 |
| 2022 | 25 | 5 | 0 | 0 | 30 |
| 2021 | 25 | 1 | 0 | 1 | 27 |
| 2020 | 52 | 5 | 0 | 0 | 57 |
| 2019 | 27 | 8 | 0 | 0 | 35 |
| 2018 | 27 | 10 | 0 | 0 | 37 |
| 2017 | 18 | 5 | 0 | 0 | 23 |
| 2016 | 34 | 4 | 0 | 0 | 38 |
| 2015 | 29 | 5 | 0 | 0 | 34 |
| 2014 | 12 | 8 | 0 | 0 | 20 |
| 2013 | 37 | 5 | 0 | 1 | 43 |
| 2012 | 42 | 4 | 1 | 6 | 53 |
| 2011 | 20 | 2 | 0 | 3 | 25 |
| 2010 | 10 | 2 | 0 | 3 | 15 |
| 2009 | 23 | 5 | 0 | 1 | 29 |
| 2008 | 7 | 3 | 0 | 2 | 12 |
| 2007 | 6 | 2 | 0 | 1 | 9 |
| 2006 | 2 | 1 | 0 | 1 | 4 |
| 2005 | 5 | 2 | 0 | 3 | 10 |
| 2004 | 6 | 0 | 0 | 1 | 7 |
| 2003 | 6 | 0 | 0 | 0 | 6 |
| 2002 | 4 | 0 | 0 | 4 | 8 |
| 2001 | 6 | 1 | 0 | 7 | 14 |
| 2000 | 6 | 0 | 0 | 5 | 11 |
| 1999 | 5 | 1 | 0 | 7 | 13 |
| 1998 | 9 | 0 | 0 | 1 | 10 |
| 1997 | 7 | 0 | 0 | 0 | 7 |
| 1996 | 6 | 3 | 0 | 0 | 9 |
| 1995 | 9 | 1 | 0 | 0 | 10 |
| 1994 | 15 | 0 | 0 | 0 | 15 |
| 1993 | 15 | 1 | 0 | 0 | 16 |
| 1992 | 5 | 0 | 0 | 0 | 5 |
| 1991 | 6 | 0 | 0 | 0 | 6 |
| 1990 | 1 | 0 | 0 | 0 | 1 |
2026 has the reports that FDA received through Jun 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal18.6%185
- Recovered with Sequela[recovered, with a lasting effect]5.8%58
- Ongoing20%199
- Died2.7%27
- Euthanized2.5%25
- Outcome Unknown22%219
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 997 reports that name neomycin sulfate + nystatin + thiostrepton + triamcinolone acetonide.
A report about more than one animal can have more than one outcome.
Kind of report
- Safety issue89.6%893
- Lack of expected effectiveness3%30
- Both safety and lack of expected effectiveness2.4%24
- Manufacturing or product defect4.8%48
- Other0.2%2
702 reports say if the event was serious. 56.8% of them have the serious flag. The person who sends the report sets the flag.
Show age, weight, breed and route
Age of the animal
- Under 1 year5.3%53
- 1 to 3 years12.7%127
- 4 to 7 years15.2%152
- 8 to 11 years27.8%277
- 12 years and over28%279
- Age not given10.9%109
Weight of the animal
- Under 5 kg (11 lb)14.4%144
- 5 to 9.9 kg (11 to 22 lb)23.3%232
- 10 to 24.9 kg (22 to 55 lb)17.8%177
- 25 to 44.9 kg (55 to 99 lb)21.2%211
- 45 kg and over (99 lb and over)3%30
- Weight not given20.4%203
Breed, where the report gives one breed
- Domestic Shorthair7.3%73
- Labrador Retriever5.1%51
- Yorkshire Terrier2.6%26
- Domestic2.5%25
- Golden Retriever2.5%25
- German Shepherd Dog2.3%23
- Shih Tzu2.1%21
- West Highland White Terrier1.7%17
A breed with many animals has many reports.
Route in the report
- Auricular (Otic)34.9%348
- Topical22%219
- Oral1.1%11
- Ophthalmic0.4%4
- Cutaneous0.3%3
- Other0.3%3
Each bar is on a scale of 0 to 100%.
Approved animal drugs with these active ingredients (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Brand names
- Panolog
- Animax
- Derma 4
- Derm-Otic
What the Green Book records give
- Applications with an approval in force
- 6
- Approved species
- Cats, Dogs
- Dose forms
- Ointment, Cream
- Routes
- Topical
- Sale
- RX (prescription)
- Earliest approval date in the records
The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| Panolog Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 012-258 |
| Panolog Cream | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 096-676 |
| Animax Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Fougera Pharmaceuticals, LLC | Dogs, Cats | NADA 140-847 |
| Derma 4 Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 140-879 |
| Derm-Otic Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 141-003 |
| Animax Cream | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Fougera Pharmaceuticals, LLC | Dogs, Cats | ANADA 200-330 |
| DERMA-VET Ointmentapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Med-Pharmex, Inc. | Dogs, Cats | NADA 140-810 |
| Derm-Otic Ointmentapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Biocraft Laboratories, Inc. | Dogs, Cats | NADA 140-889 |
| Derma-Vet Creamapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Med-Pharmex, Inc. | Dogs, Cats | ANADA 200-245 |
Other pages with one of these ingredients
A report names a drug by its set of active ingredients. Each set has its own page. The list is in order of name.
- Neomycin Sulfate, all combinations
- Nystatin, all combinations
- Thiostrepton, all combinations
- Triamcinolone Acetonide, all combinations
- Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate
- Dexamethasone + Neomycin Sulfate + Thiabendazole
- Isoflupredone Acetate + Neomycin Sulfate + Tetracaine Hydrochloride
- Neomycin Sulfate
- Neomycin Sulfate + Nystatin
- Neomycin Sulfate + Nystatin + Thiostrepton
- Neomycin Sulfate + Tetracaine Hydrochloride
- Nystatin
- Nystatin + Thiostrepton + Triamcinolone
- Nystatin + Thiostrepton + Triamcinolone Acetonide
- Triamcinolone Acetonide
Next in the A to Z list
FDA pages for this drug
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Green Book record of NADA 012-258The FDA record of the application for Panolog Ointment.
- Green Book record of NADA 096-676The FDA record of the application for Panolog Cream.
- Green Book record of NADA 140-847The FDA record of the application for Animax Ointment.
- Green Book record of NADA 140-879The FDA record of the application for Derma 4 Ointment.
- Green Book record of NADA 141-003The FDA record of the application for Derm-Otic Ointment.
- Green Book record of ANADA 200-330The FDA record of the application for Animax Cream.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Neomycin Sulfate + Nystatin + Thiostrepton + Triamcinolone Acetonide: adverse event reports that FDA received. https://petdrugreports.com/drug/neomycin-sulfate-nystatin-thiostrepton-triamcinolone-acetonide/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. The site does not use the application number that a record has.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists the brand names with these active ingredients.
- Do the reports show that the drug caused the signs?
No. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 150 reports in the 12 months to June 2026. It received 98 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 997 reports received from March 1990 to June 2026, 89.6% are about a safety issue only. 5.4% are about a lack of expected effectiveness, alone or with a safety issue. 4.8% are about a defect of the product or its package.